search
hormone therapy
Trends
- 1Retatrutide Shows Record Weight Loss in Type 2 Diabetes Trial▼Triple Agonist Retatrutide Pushes Weight Loss to New Levels in Type 2 Diabetes
Eli Lilly's triple agonist retatrutide has been reported to push weight loss to new levels among patients with type 2 diabetes, according to Inside Precision Medicine. The drug, which targets three hormone receptors, is being studied as one of the most powerful obesity and diabetes treatments in development, extending gains seen with tirzepatide and semaglutide.
- 2
The Trump administration has asked the US Supreme Court to block gender-affirming care for transgender prisoners, escalating its legal campaign against such treatment. The request goes directly to the nation's highest court and concerns inmates' access to hormone therapy and related medical care while incarcerated. Civil rights groups are expected to oppose the move, arguing it violates constitutional protections against cruel and unusual punishment.
- 3House Democratic Women's Caucus presses health secretary on estrogen patch shortages●US House Democratic Women's Caucus press health secretary on estrogen patch shortages
Members of the US House Democratic Women's Caucus are pressing the health secretary over shortages of estrogen patches, a hormone replacement therapy product many women rely on. The caucus is demanding answers on supply problems and what the administration is doing to restore availability, keeping drug shortages and women's health access in the political spotlight.